ID

34433

Description

Better Adherence With New Oral Anticoagulant in Atrial Fibrillation : Effectiveness of a Personalized Education Program; ODM derived from: https://clinicaltrials.gov/show/NCT02422602

Lien

https://clinicaltrials.gov/show/NCT02422602

Mots-clés

  1. 17/01/2019 17/01/2019 -
  2. 04/03/2020 04/03/2020 - Christian Arras
  3. 05/03/2020 05/03/2020 - Sarah Riepenhausen
Détendeur de droits

see on clinicaltrials.gov

Téléchargé le

17 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Non-valvular Atrial Fibrillation NCT02422602

Eligibility Non-valvular Atrial Fibrillation NCT02422602

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
all patients treated with rivaroxaban chronically, (atrial fibrillation non-valvular under current amm) for less than one year whatever anti vitamin k treatment history
Description

ID.1

Type de données

boolean

affiliate or beneficiary of a social security system.
Description

ID.2

Type de données

boolean

patient who formulated its "does not oppose" to participate in this research
Description

ID.3

Type de données

boolean

age higher than or equal to 18 years
Description

ID.4

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
opposition to participation
Description

ID.5

Type de données

boolean

patient don't understand french language
Description

ID.6

Type de données

boolean

patient does not have responsibility for the management of treatment (treatment administered by a nurse at home, or by caregivers)
Description

ID.7

Type de données

boolean

tutorship or curatoship
Description

ID.8

Type de données

boolean

law-protected patient
Description

ID.9

Type de données

boolean

pregnant women or breast-feeding
Description

ID.10

Type de données

boolean

Similar models

Eligibility Non-valvular Atrial Fibrillation NCT02422602

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
all patients treated with rivaroxaban chronically, (atrial fibrillation non-valvular under current amm) for less than one year whatever anti vitamin k treatment history
boolean
ID.2
Item
affiliate or beneficiary of a social security system.
boolean
ID.3
Item
patient who formulated its "does not oppose" to participate in this research
boolean
ID.4
Item
age higher than or equal to 18 years
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
opposition to participation
boolean
ID.6
Item
patient don't understand french language
boolean
ID.7
Item
patient does not have responsibility for the management of treatment (treatment administered by a nurse at home, or by caregivers)
boolean
ID.8
Item
tutorship or curatoship
boolean
ID.9
Item
law-protected patient
boolean
ID.10
Item
pregnant women or breast-feeding
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial